What is the treatment for septic shock?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Septic Shock

The treatment of septic shock requires immediate administration of broad-spectrum antibiotics within one hour of recognition, aggressive fluid resuscitation with 30 mL/kg crystalloid for hypotension or lactate ≥4 mmol/L, and vasopressor therapy with norepinephrine as the first-line agent to maintain mean arterial pressure ≥65 mmHg. 1

Initial Resuscitation and Hemodynamic Support

Fluid Resuscitation

  • Administer 30 mL/kg crystalloid (approximately 2L for average adult) for hypotension or lactate ≥4 mmol/L within the first hours 1, 2
  • After initial bolus, further fluid administration should be guided by dynamic parameters, clinical condition, and echocardiography 2
  • Both balanced crystalloids and normal saline are reasonable options for resuscitation 3

Vasopressor Therapy

  1. First-line: Norepinephrine to maintain MAP ≥65 mmHg 1, 3
  2. Second-line: Add vasopressin (up to 0.03 U/min) to decrease norepinephrine requirements 1, 3
  3. Third-line: Add epinephrine if target MAP is not achieved with above measures 1, 3
  4. Dopamine should only be used in highly selected patients with low risk of tachyarrhythmias 1
  5. Place arterial catheter as soon as practical for patients requiring vasopressors 1
    • Vasopressors can be safely administered through a peripheral 20-gauge or larger IV line if central access is delayed 3

Antimicrobial Therapy

Timing and Selection

  • Administer broad-spectrum antibiotics within the first hour of recognizing septic shock 1, 3, 2
  • Select antibiotics with activity against likely pathogens and good penetration into the presumed source 4

Recommended Regimens

  • Moderate risk patients: Monotherapy with meropenem, imipenem/cilastatin, piperacillin/tazobactam, or ceftazidime 1
  • High-risk patients: Combination therapy with antipseudomonal beta-lactam plus aminoglycoside 1
  • Consider adding vancomycin if suspected catheter-related infection, known MRSA colonization, skin/soft tissue infection, or hemodynamic instability 1
  • Administer beta-lactam antibiotics as prolonged or continuous infusion after an initial loading dose 2

Pathogen-Specific Therapy

  • E. coli: Third-generation cephalosporins or piperacillin/tazobactam 1
  • S. aureus: Vancomycin for 4-6 weeks 1
  • Candida species: Amphotericin B or fluconazole for susceptible strains 1
  • Carbapenem-resistant Klebsiella: Newer agents like ceftolozane/tazobactam, ceftazidime/avibactam, or meropenem-vaborbactam 1

Duration and De-escalation

  • Typical duration: 7-10 days 1, 4
  • Reassess antimicrobial regimen daily for potential de-escalation based on culture results and clinical improvement 1, 5
  • Consider procalcitonin levels to guide discontinuation of antibiotics 1, 2

Source Control

  • Identify and control the source of infection within 12 hours 1
  • Remove infected catheters or devices 1
  • Surgical intervention may be necessary for abscesses, infected necrotic tissue, or other controllable sources 2

Adjunctive Therapies

Corticosteroids

  • IV hydrocortisone 200 mg/day as continuous infusion only for septic shock not responsive to adequate fluid resuscitation and vasopressor therapy 1, 3
  • Taper when vasopressors are no longer required 1
  • Consider combination of hydrocortisone and fludrocortisone for refractory septic shock 3

Blood Product Administration

  • Transfuse RBCs only when hemoglobin <7.0 g/dL (target 7.0-9.0 g/dL) once tissue hypoperfusion has resolved 1
  • Administer platelets prophylactically when counts <10,000/mm³ without bleeding, <20,000/mm³ with significant bleeding risk, or ≥50,000/mm³ for active bleeding, surgery, or invasive procedures 1

Ventilator Management (if needed)

  • Target tidal volume of 6 mL/kg predicted body weight 1
  • Maintain plateau pressures ≤30 cm H2O 1
  • Apply PEEP to avoid alveolar collapse 1
  • Consider prone positioning for PaO2/FiO2 ratio ≤100 mm Hg 1
  • Elevate head of bed to 30-45 degrees 1

Monitoring and Assessment

  • Target resuscitation goals: MAP ≥65 mmHg, improved mental status, normalized capillary refill time, decreasing lactate, and urine output ≥0.5 ml/kg/h 1, 3
  • Perform daily assessment of clinical improvement, hemodynamic stability, inflammatory markers, and organ function 1
  • Patients showing ongoing signs of infection beyond 7 days warrant diagnostic investigation and multidisciplinary re-evaluation 1

Special Considerations

  • Pregnancy: Do not withhold life-sustaining therapy. Hypotension associated with septic shock is a medical emergency that can be fatal if left untreated 6
  • Elderly patients: Start at lower doses, considering decreased hepatic, renal, or cardiac function 6

Common Pitfalls to Avoid

  • Delaying antibiotic administration beyond one hour of recognition
  • Inadequate source control
  • Excessive fluid administration after initial resuscitation
  • Failure to de-escalate antibiotics based on culture results
  • Using corticosteroids in sepsis without shock
  • Continuing antibiotics beyond 7-10 days without clear indication

References

Guideline

Sepsis Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[Guideline-conform treatment of sepsis].

Die Anaesthesiologie, 2024

Research

Emergency medicine updates: Management of sepsis and septic shock.

The American journal of emergency medicine, 2025

Research

Antimicrobial management of sepsis and septic shock.

Clinics in chest medicine, 2008

Research

Empiric Antibiotics for Sepsis.

Surgical infections, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.